| Title |
Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity
|
|---|---|
| Published in |
Psychopharmacology, September 2011
|
| DOI | 10.1007/s00213-011-2466-2 |
| Pubmed ID | |
| Authors |
Joanna E. Fardell, Janette Vardy, Jeanette D. Shah, Ian N. Johnston |
| Abstract |
Studies in women with breast cancer, and in animal models, have demonstrated that chemotherapy can have a negative impact on cognitive function. Which chemotherapy agents cause problems with cognition and the aetiology of the impairment is unknown. Furthermore, there is no proven treatment. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | 33% |
| Australia | 2 | 33% |
| Unknown | 2 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 4 | 67% |
| Members of the public | 2 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 135 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | <1% |
| Unknown | 134 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 29 | 21% |
| Student > Bachelor | 17 | 13% |
| Student > Doctoral Student | 14 | 10% |
| Researcher | 12 | 9% |
| Student > Master | 12 | 9% |
| Other | 24 | 18% |
| Unknown | 27 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 24 | 18% |
| Medicine and Dentistry | 18 | 13% |
| Neuroscience | 12 | 9% |
| Agricultural and Biological Sciences | 11 | 8% |
| Sports and Recreations | 10 | 7% |
| Other | 29 | 21% |
| Unknown | 31 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 November 2018.
All research outputs
#4,565,399
of 22,751,628 outputs
Outputs from Psychopharmacology
#1,197
of 5,340 outputs
Outputs of similar age
#25,344
of 125,748 outputs
Outputs of similar age from Psychopharmacology
#12
of 42 outputs
Altmetric has tracked 22,751,628 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,340 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 125,748 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.